CoRE Seminar Series: Evolving Regulations to Facilitate Access to Cell, Tissue and Gene Therapies

Start Date & Time: 
Tuesday, 21 November, 2017 - 15:30
End Date & Time: 
Tuesday, 21 November, 2017 - 17:30

Amphitheatre, Duke-NUS Medical School, Level 2

Speaker Details: 
Dr. Patrick Celis
Head of Scientific Secretariat 
Committee for Advanced Therapies 
European Medicines Agency (EMA) 
As medical management moves beyond the traditional pills, tablets and injections, the arrival of new treatment modalities in the form of cells, tissues and gene therapies have gained the attention of many in the healthcare environment. While these products hold new promises and advances in medical sciences, it also poses new challenges and concerns across various stakeholders. 
CoRE welcomes you to join us for a complimentary seminar by Dr Patrick Celis. With over a decade of experience in advanced therapies, he will share how health product regulations have evolved to accommodate new sciences and allow access to advanced therapies.
Prof John Lim 
Executive Director, CoRE
Duke- NUS Medical School 
& Senior Adviser
Ministry of Health, Singapore 
Contact Person: 
Sherna Wadia